Drug information for DOXERCALCIFEROL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
0.5MCG
Prescription
AB
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
ROXANE
91433
2011-11-07 Letter
CAPSULE; ORAL
1MCG
Tentative Approval
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
ROXANE
"
CAPSULE; ORAL
2.5MCG
Tentative Approval
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
ROXANE
"
INJECTABLE; INJECTION
2MCG/ML
Tentative Approval
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
COBREK PHARMA
90040
2011-03-18 Letter
INJECTABLE; INJECTION
2MCG/ML
Tentative Approval
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
MYLAN PHARMA
91101
INJECTABLE; INJECTION
2MCG/ML
Tentative Approval
DOXERCALCIFEROL
1 alpha-hydroxyergocalciferol
SANDOZ
91333
Drug Adverse Effects information for DOXERCALCIFEROL
Role code
Indications
Reaction
# Reports
C
NUCLEAR MAGNETIC RESONANCE IMAGING
GAIT DISTURBANCE
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
LOCALISED OEDEMA
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
MUSCULOSKELETAL STIFFNESS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
NEPHROGENIC SYSTEMIC FIBROSIS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PAIN
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
PAIN IN EXTREMITY
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
RASH MACULAR
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN FIBROSIS
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN HYPERPIGMENTATION
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN HYPERTROPHY
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN INDURATION
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN PLAQUE
3
C
NUCLEAR MAGNETIC RESONANCE IMAGING
SKIN TIGHTNESS
3
Ads by Google